Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 25, 2018		Mar. 26, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 1,359,535		$ 1,171,339
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	241,276		227,869
Deferred income taxes	(209,214)		69,867
Equity-based compensation expense	125,002		106,173
Impairment of investment	42,456		0
Loss on extinguishment of debt	0		36,325
Amortization of note discounts and issuance costs	13,469		19,168
Other, net	23,327		10,777
Changes in operating assets and liabilities	341,538		(341,508)
Net cash provided by operating activities	1,937,389		1,300,010
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(193,814)		(122,608)
Business acquisition, net of cash acquired	(115,697)		0
Purchases of available-for-sale securities	(2,377,459)		(3,594,060)
Sales and maturities of available-for-sale securities	4,188,870		1,616,316
Transfers of restricted cash and investments	(382)		(5,736)
Other, net	(14,358)		(11,627)
Net cash provided by (used for) investing activities	1,487,160		(2,117,715)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs	(577,415)		(1,685,868)
Net proceeds from issuance of commercial paper	997,971		0
Proceeds from borrowings on revolving credit facility	750,000		0
Repayments of borrowings on revolving credit facility	(750,000)		0
Treasury stock purchases	(1,346,940)		(285,894)
Dividends paid	(225,604)		(169,786)
Reissuance of treasury stock related to employee stock purchase plan	34,057		36,543
Proceeds from issuance of common stock	6,632		12,544
Other, net	11		(124)
Net cash used for financing activities	(1,111,288)		(2,092,585)
Effect of exchange rate changes on cash and cash equivalents	8,200		(462)
Net increase (decrease) in cash and cash equivalents	2,321,461		(2,910,752)
Cash and cash equivalents at beginning of period	2,377,534	[1]	5,039,322
Cash and cash equivalents at end of period	4,698,995		2,128,570
Schedule of non-cash transactions:
Accrued payables for stock repurchases	2,165		2,272
Accrued payables for capital expenditures	32,610		10,077
Dividends payable	82,030		73,953
Transfers of inventory to property and equipment, net	$ 38,878		$ 35,972

[1] Derived from audited financial statements